To investigate whether PTP inhibition led to an improved metabolic phenotype after induction of insulin resistance, HFD mice were pharmacologically treated with the specific SHP‐1 inhibitor sodium stibogluconate or the broad spectrum pan‐PTP inhibitor BMOV for 6 weeks. This evidence concerns the gene PTPN6 and Insulin resistance.